Skip to main content
ConductScienceScienceDex

David S. Rickman

From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.

FY2026 NIH rank #13,963
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9368172Search this ID in NIH RePORTER
ORCID iD
https://orcid.org/0000-0001-7420-5883Verified identifier for this researcher
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Urology
  • Pathology

NIH Funding · FY2026

Linked Award Amount
$1.5M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#13,963
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for David S. Rickman. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

NCI

National Cancer Institute

$1.5M

3 awards · administering

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing David S. Rickman as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA301637-02R01Co-investigator
    The role of early oncogenic drivers in maintaining lineage fidelity in prostate cancer
    Weill Cornell Medicine · Urology (NIH department code)
    $656K
    award amount
  • 5R01CA274963-04R01Contact PI
    "DNMT and TET1 reprogramming as a targetable mechanism of resistance in advanced prostate cancer"
    Weill Cornell Medicine · Pathology (NIH department code)
    $645.5K
    award amount
  • 1R03CA308672-01R03Contact PI
    Characterizing the cooperative role of E2F1 and interacting proteins in driving advanced prostate cancer
    Weill Cornell Medicine · Pathology (NIH department code)
    $169.3K
    award amount

Award organization

Organizations that administered FY2026 awards listing David S. Rickman as a PI.

FY2026 award administered by Weill Cornell Medicine (NY).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Weill Cornell Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    R01 Grant Holder
  5. 2026
    $2M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as David S. Rickman.

Himisha Beltran
Weill Cornell Medicine
3
shared awards
Christopher E Barbieri
Weill Cornell Medicine
2
shared awards

Explore further

Find collaborators for David S. Rickman

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →